Literature DB >> 17587343

Protective acquired immunity to Enteromyxum scophthalmi (Myxozoa) is related to specific antibodies in Psetta maxima (L.) (Teleostei).

A Sitjà-Bobadilla1, O Palenzuela1, A Riaza1, M A Macías1, P Alvarez-Pellitero1.   

Abstract

The acquired protection of three groups of turbot that had survived enteromyxosis outbreaks was tested by challenging with E. scophthalmi in three different experiments. The relation of such a response with the kinetics and duration of antibody production (determined by an ELISA) was studied. The progression of the infection was evaluated by PCR. In experiments 1 and 2, in which turbot had cohabited with highly infected fish during outbreaks, parasite prevalence and mortality were very low or null, and there was a progressive and statistically significant increase in the mean antibody production up to 350 and 152 days post-exposure respectively. By contrast, in experiment 3, fish (coming from non-infected tanks during the initial outbreak), both infection prevalence and cumulative mortality reached 92.8%, and specific antibodies were detected only in two fish. The observed differences in mortality after challenge appear to be related to the production of specific antibodies and it is probably accompanied by a repertoire of mechanisms of innate immunity. The exploitation of the immune system through breeding selection programmes as a possible strategy to control the disease is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17587343     DOI: 10.1111/j.1365-3083.2007.01942.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

Review 1.  Biology and mucosal immunity to myxozoans.

Authors:  Daniela Gómez; Jerri Bartholomew; J Oriol Sunyer
Journal:  Dev Comp Immunol       Date:  2013-08-29       Impact factor: 3.636

2.  Defenses of susceptible and resistant Chinook salmon (Oncorhynchus tshawytscha) against the myxozoan parasite Ceratomyxa shasta.

Authors:  Sarah J Bjork; Yong-An Zhang; Charlene N Hurst; Maria E Alonso-Naveiro; Julie D Alexander; J Oriol Sunyer; Jerri L Bartholomew
Journal:  Fish Shellfish Immunol       Date:  2014-01-08       Impact factor: 4.581

3.  Pathogenic endoparasites of the spotted seatrout, Cynoscion nebulosus: patterns of infection in estuaries of South Carolina, USA.

Authors:  Stephen A Arnott; Iva Dyková; William A Roumillat; Isaure de Buron
Journal:  Parasitol Res       Date:  2017-05-02       Impact factor: 2.289

Review 4.  B cells and their role in the teleost gut.

Authors:  David Parra; Tomáš Korytář; Fumio Takizawa; J Oriol Sunyer
Journal:  Dev Comp Immunol       Date:  2016-03-16       Impact factor: 3.636

5.  RNA-seq analysis reveals significant transcriptome changes in turbot (Scophthalmus maximus) suffering severe enteromyxosis.

Authors:  Diego Robledo; Paolo Ronza; Peter W Harrison; Ana Paula Losada; Roberto Bermúdez; Belén G Pardo; María José Redondo; Ariadna Sitjà-Bobadilla; María Isabel Quiroga; Paulino Martínez
Journal:  BMC Genomics       Date:  2014-12-19       Impact factor: 3.969

Review 6.  Integrating Genomic and Morphological Approaches in Fish Pathology Research: The Case of Turbot (Scophthalmus maximus) Enteromyxosis.

Authors:  Paolo Ronza; Diego Robledo; Roberto Bermúdez; Ana Paula Losada; Belén G Pardo; Paulino Martínez; María Isabel Quiroga
Journal:  Front Genet       Date:  2019-01-31       Impact factor: 4.599

7.  Passive Immunization Delays Disease Outcome in Gilthead Sea Bream Infected With Enteromyxum leei (Myxozoa), Despite the Moderate Changes in IgM and IgT Repertoire.

Authors:  Amparo Picard-Sánchez; Itziar Estensoro; Pedro Perdiguero; Raquel Del Pozo; Carolina Tafalla; M Carla Piazzon; Ariadna Sitjà-Bobadilla
Journal:  Front Immunol       Date:  2020-09-11       Impact factor: 7.561

Review 8.  To React or Not to React: The Dilemma of Fish Immune Systems Facing Myxozoan Infections.

Authors:  Astrid S Holzer; M Carla Piazzon; Damien Barrett; Jerri L Bartholomew; Ariadna Sitjà-Bobadilla
Journal:  Front Immunol       Date:  2021-09-16       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.